James Paskavitz

624 total citations
19 papers, 479 citations indexed

About

James Paskavitz is a scholar working on Cognitive Neuroscience, Psychiatry and Mental health and Rheumatology. According to data from OpenAlex, James Paskavitz has authored 19 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cognitive Neuroscience, 5 papers in Psychiatry and Mental health and 4 papers in Rheumatology. Recurrent topics in James Paskavitz's work include Dementia and Cognitive Impairment Research (4 papers), Neural and Behavioral Psychology Studies (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). James Paskavitz is often cited by papers focused on Dementia and Cognitive Impairment Research (4 papers), Neural and Behavioral Psychology Studies (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). James Paskavitz collaborates with scholars based in United States and United Kingdom. James Paskavitz's co-authors include Amy Chan, Thomas B. Shea, Ruth Remington, Ronald A. Cohen, Lawrence H. Sweet, John Gunstad, Spero R. Cataland, Marie Scully, Paul Maruff and Haifeng Wu and has published in prestigious journals such as Neurology, Annals of Neurology and Neuropsychologia.

In The Last Decade

James Paskavitz

18 papers receiving 469 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Paskavitz United States 10 131 89 85 76 66 19 479
Sen-yang Lang China 17 134 1.0× 56 0.6× 55 0.6× 228 3.0× 61 0.9× 39 681
Triantafyllos Doskas Greece 11 86 0.7× 39 0.4× 23 0.3× 72 0.9× 90 1.4× 25 447
Chihiro Kaneko Japan 11 357 2.7× 55 0.6× 38 0.4× 32 0.4× 45 0.7× 15 678
J.M. Gandon France 12 69 0.5× 96 1.1× 74 0.9× 113 1.5× 167 2.5× 22 717
Kamyar Moradi Iran 13 59 0.5× 53 0.6× 72 0.8× 78 1.0× 29 0.4× 41 413
Andrew J. Kwilasz United States 12 261 2.0× 40 0.4× 20 0.2× 64 0.8× 45 0.7× 21 564
Melissa O’Brien Canada 10 206 1.6× 29 0.3× 102 1.2× 38 0.5× 14 0.2× 16 554
Justyna Chojdak-Łukasiewicz Poland 14 88 0.7× 43 0.5× 20 0.2× 94 1.2× 112 1.7× 50 589
Danilov Ab Russia 13 233 1.8× 81 0.9× 44 0.5× 211 2.8× 51 0.8× 56 576
Antonio Martínez‐Salio Spain 14 175 1.3× 84 0.9× 44 0.5× 288 3.8× 197 3.0× 36 784

Countries citing papers authored by James Paskavitz

Since Specialization
Citations

This map shows the geographic impact of James Paskavitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Paskavitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Paskavitz more than expected).

Fields of papers citing papers by James Paskavitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Paskavitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Paskavitz. The network helps show where James Paskavitz may publish in the future.

Co-authorship network of co-authors of James Paskavitz

This figure shows the co-authorship network connecting the top 25 collaborators of James Paskavitz. A scholar is included among the top collaborators of James Paskavitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Paskavitz. James Paskavitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Nguyen, David P., Anne C. Smith, E. Hoffman, et al.. (2020). Mechanistic PK/PD Model of Neuroactive Steroid GABAA Positive Allosteric Modulation and Effects on TETRAS Assessment in Essential Tremor (4499). Neurology. 94(15_supplement). 1 indexed citations
4.
Bove, Riley, Charles C. White, Gavin Giovannoni, et al.. (2015). Evaluating more naturalistic outcome measures. Neurology Neuroimmunology & Neuroinflammation. 2(6). 46 indexed citations
6.
Cataland, Spero R., Marie Scully, James Paskavitz, et al.. (2010). Evidence of persistent neurologic injury following thrombotic thrombocytopenic purpura. American Journal of Hematology. 86(1). 87–89. 60 indexed citations
7.
Paskavitz, James, Lawrence H. Sweet, Jeremy Wellen, et al.. (2009). Recruitment and Stabilization of Brain Activation Within a Working Memory Task; an fMRI Study. Brain Imaging and Behavior. 4(1). 5–21. 4 indexed citations
8.
Chan, Amy, et al.. (2008). Efficacy of a Vitamin/Nutriceutical Formulation for Early-stage Alzheimer's Disease: A 1-year, Open-label Pilot Study With an 16-Month Caregiver Extension. American Journal of Alzheimer s Disease & Other Dementias®. 23(6). 571–585. 100 indexed citations
9.
Browndyke, Jeffrey N., James Paskavitz, Lawrence H. Sweet, et al.. (2008). Neuroanatomical correlates of malingered memory impairment: Event-related fMRI of deception on a recognition memory task. Brain Injury. 22(6). 481–489. 31 indexed citations
10.
Shea, Thomas B., et al.. (2008). P4‐345: A vitamin/nutriceutical formulation that delays cognitive decline and improves behavioral symptoms in Alzheimer's disease. Alzheimer s & Dementia. 4(4S_Part_24). 2 indexed citations
11.
Chan, Amy, Ruth Remington, James Paskavitz, & Thomas Shea. (2008). The Clock-Drawing Test: Time for a Change?. American Journal of Alzheimer s Disease & Other Dementias®. 23(4). 377–381.
12.
Remington, Ruth, Amy Chan, James Paskavitz, & Thomas B. Shea. (2008). Efficacy of a Vitamin/Nutriceutical Formulation for Moderate-stage to Later-stage Alzheimer's disease: A Placebo-controlled Pilot Study. American Journal of Alzheimer s Disease & Other Dementias®. 24(1). 27–33. 109 indexed citations
13.
Sweet, Lawrence H., James Paskavitz, Andreana P. Haley, et al.. (2007). Imaging phonological similarity effects on verbal working memory. Neuropsychologia. 46(4). 1114–1123. 41 indexed citations
14.
Chan, Amy, James Paskavitz, & Thomas B. Shea. (2007). P‐011: A novel vitamin/nutraceutical formulation that delays cognitive decline and improves mood in early‐stage Alzheimer's disease. Alzheimer s & Dementia. 3(3S_Part_1). 3 indexed citations
15.
Paskavitz, James, et al.. (2007). Clock Drawing and Frontal Lobe Behavioral Effects of Memantine in Alzheimer’s Disease: A Rater-Blinded Study. American Journal of Alzheimer s Disease & Other Dementias®. 21(6). 454–459. 5 indexed citations
16.
Sweet, Lawrence H., et al.. (2005). FMRI correlates of the WAIS–III Symbol Search subtest. Journal of the International Neuropsychological Society. 11(4). 471–476. 20 indexed citations
17.
Filley, Christopher M., et al.. (1999). White matter dementia in CADASIL. Journal of the Neurological Sciences. 163(2). 163–167. 20 indexed citations
18.
Paskavitz, James, Curtis A. Anderson, Christopher M. Filley, Bette K. Kleinschmidt‐DeMasters, & Kenneth L. Tyler. (1995). Acute arcuate fiber demyelinating encephalopathy following epstein‐barr virus infection. Annals of Neurology. 38(1). 127–131. 17 indexed citations
19.
Paskavitz, James, C F Lippa, James E. Hamos, D. Pulaski-Salo, & David A. Drachman. (1995). Role of the dorsomedial nucleus of the thalamus in Alzheimer's disease.. PubMed. 8(1). 32–7. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026